Tuesday, August 31, 2021 6:47:16 AM
This doesn't even need a buyout just a profitable collaboration or deal with some deep pockets. RGBP is already making money from the first deal with ONPH. For sure the CEO is not going to just sit on those patents, my thought is that there is some plan that is moving forward. Watch for a 8K with a major player and yesterday will be a little hiccup. JMO
https://www.oncology-pharma.com/science-technology
https://www.oncology-pharma.com/science-technology
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
